FDA accepts two of MSD’s new drug applications
MSD has announced that the US Food and Drug Administration (FDA) has accepted for review New Drug Applications (NDA) for two of its antibacterial agents.
Read More
Tag: Zerbaxa
MSD to file antibiotic Zerbaxa for pneumonia
MSD is gearing up to file antibiotic Zerbaxa on both sides of the Atlantic for certain forms of pneumonia on the success of a late-stage trial backing its safety and efficacy.
Read More
Three new medicines approved for NHS Scotland
The Scottish Medicines Consortium has accepted three new medicines for routine use on NHS Scotland, expanding treatment options for cervical cancer, HIV and a skin condition called hidradenitis suppurativa, but has turned away an antibiotic and two medicines for cystic fibrosis.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
